The Astron Multigrain IPO is a closed SME Fixed Price offer (Fresh Capital-cum-Offer for Sale) that opened on 1 December 2025. The Astron Multigrain IPO closed on 3 December 2025, with an issue price of ₹63 per share. The Astron Multigrain IPO has a face value of ₹10 and a lot size of 2,000 shares. The Astron Multigrain IPO is listed on 8 December 2025. The Astron Multigrain IPO allotment was scheduled for 4 December 2025.
On the financial front, the Astron Multigrain IPO reported revenue of ₹24 crore for 31 Oct 2025, compared with ₹34 crore for 31 Mar 2025. The Astron Multigrain IPO PAT was ₹2 crore against ₹2 crore. The Astron Multigrain IPO EBITDA stood at ₹3 crore with a 11.98% margin. The Astron Multigrain IPO net worth as of 31 Oct 2025 was ₹13 crore.
Always verify The Astron Multigrain IPO details and GMP data with the official offer document before investing in the Astron Multigrain IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Oct 2025
31 Mar 2025
31 Mar 2024
Total Assets
28
22
18
Revenue
24
34
27
PAT
2
2
2
EBITDA
3
4
3
Net Worth
13
11
8
Reserves
6
4
2
Total Borrowing
3
4
5
Astron Multigrain IPO Financials FAQs
Revenue of Astron Multigrain (Amount in ₹ Crore) — 31 Oct 2025: 24; 31 Mar 2025: 34; 31 Mar 2024: 27. Profit after tax (PAT) — 31 Oct 2025: 2; 31 Mar 2025: 2; 31 Mar 2024: 2.
EBITDA of Astron Multigrain (Amount in ₹ Crore) — 31 Oct 2025: 3; 31 Mar 2025: 4; 31 Mar 2024: 3. The EBITDA margin is 11.98%.
Total assets — 31 Oct 2025: 28; 31 Mar 2025: 22; 31 Mar 2024: 18. Net worth — 31 Oct 2025: 13; 31 Mar 2025: 11; 31 Mar 2024: 8. Reserves & surplus — 31 Oct 2025: 6; 31 Mar 2025: 4; 31 Mar 2024: 2. (Amount in ₹ Crore)
Total borrowing of Astron Multigrain (Amount in ₹ Crore) — 31 Oct 2025: 3; 31 Mar 2025: 4; 31 Mar 2024: 5. Debt-to-equity ratio: 0.41.
The financials shown for Astron Multigrain IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
